PHC Holdings

SciMed (Asia) Pte Ltd. is a Singapore-based company that specializes in the distribution of laboratory equipment and supplies, including cleanroom products, cell culture media, antibodies, and immunoassays. Established in 1992, the company serves various sectors such as agriculture, biopharmaceuticals, education, healthcare, industrial laboratories, medical devices, pharmaceuticals, and research life sciences. In addition to providing a comprehensive range of laboratory instruments and reagents, SciMed (Asia) offers biodecontamination and scientific services to support clients in meeting their research and scientific needs. As of July 2020, it operates as a subsidiary of PHC Holdings Corporation.

Lunaphore develops automated tissue staining platforms for spatial biology research. Its technology uses microfluidic chips to analyze and classify tumors, enabling efficient cancer diagnostic assays.

Lunaphore develops automated tissue staining platforms for spatial biology research. Its technology uses microfluidic chips to analyze and classify tumors, enabling efficient cancer diagnostic assays.

Founded in 2013 as a spin-off from the University of Helsinki's Finnish Institute for Molecular Medicine, Aiforia specializes in cloud-based microscopy and pathology. Its platform combines deep learning AI and high-performance cloud computing to provide efficient, scalable solutions for image-based diagnostics across various fields.

Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for individuals with diabetes. Founded in 1996, the company focuses on innovative and long-term implantable glucose monitoring solutions that utilize advanced fluorescence sensing technology. Its flagship products, Eversense and Eversense XL, are implantable CGM systems designed to monitor glucose levels for up to 90 and 180 days, respectively. These products aim to provide users with a reliable and stable means of glucose management, enhancing their ability to live confidently and manage their diabetes effectively. The majority of Senseonics' revenue comes from international markets, reflecting its strong presence in Europe.

Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for individuals with diabetes. Founded in 1996, the company focuses on innovative and long-term implantable glucose monitoring solutions that utilize advanced fluorescence sensing technology. Its flagship products, Eversense and Eversense XL, are implantable CGM systems designed to monitor glucose levels for up to 90 and 180 days, respectively. These products aim to provide users with a reliable and stable means of glucose management, enhancing their ability to live confidently and manage their diabetes effectively. The majority of Senseonics' revenue comes from international markets, reflecting its strong presence in Europe.

Lunaphore develops automated tissue staining platforms for spatial biology research. Its technology uses microfluidic chips to analyze and classify tumors, enabling efficient cancer diagnostic assays.

KAKEHASHI Inc. is a Tokyo-based company established in 2016 that specializes in developing software as a service (SaaS) applications tailored for health insurance claim and drug history management, specifically designed for dispensing pharmacists using iPads. The company's mission is to bridge the gap between medical treatment and patients, aiming to enhance the healthcare landscape in Japan, which is known for its advanced medical technology and systems. As Japan faces a rapidly aging population, with projections indicating that by 2060, a significant portion of the population will be over 65, KAKEHASHI is committed to innovating healthcare solutions that support and improve the quality of life for this demographic, thereby contributing to the future of medical care in the country.

Ascensia Diabetes Care is a global company specializing in blood glucose monitoring systems, lancing devices, and diabetes management software. Headquartered in Basel, Switzerland, the company aims to improve the lives of people with diabetes by empowering them to manage their health effectively.

Millennial Net's flagship platform, MeshScape, offers highly scalable, low power, reliable wireless mesh networking capability that is beyond any conventional WSN technologies. Millennial Net also provides Wireless Energy Management and Energy Efficiency solutions focused on commercial and public building applications. Typically save 15%-30% of a buildings current energy consumption.